1. March 23, 14. Kimchi-Sarfaty, C., Oh, J. M., Kim, I.-W., Sauna, Z. E., Calcagno, A. M., Ambudkar, S. V., and Gottesman, M. M. A. (2007). A “silent” polymorphism in the MDR1 gene changes substrate specificity, Science, 315, pp. 525–528. 15. Sauna, Z. E., Kimchi-Sarfaty, C., Ambudkar, S. V., and Gottesman, M. M. (2007). Silent polymorphisms speak: how they affect pharmacogenomicsand the treatment of cancer, Cancer Res., 67, pp. 9609–9612. 16. Przybyla-Zawislak, B. D., Srivastava, P. K., Va´zquez-Matı´as, J., Mohrenweiser, H. W., Maxwell, J. E., Hammock, B. D., Bradbury, J. A., Enayetallah, A. E., Zeldin, D. C., and Grant, D. F. (2003). Polymorphisms in human soluble epoxide hydrolase,Mol. Pharmacol., 64, pp. 482–490. 17. Takeuchi, F., McGinnis, R., Bourgeois, S., Barnes, C., Eriksson, N., Soranzo, N., Whittaker, P., Ranganath, V., Kumanduri, V., McLaren, W., Holm, L., Lindh, J., Rane, A., Wadelius, M., and Deloukas, P. (2009). A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose, PLOS Genet., 5, p. e1000433. 18. Komar, A. A., Lesnik, T., and Reiss, C. (1999). Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation, FEBS Lett., 462, pp. 387–391. 19. Komar, A. A. (2007). Genetics. SNPs, silent but not invisible, Science, 315, pp. 466–467. 20. Luco, R. F., Pan, Q., Tominaga, K., Blencowe, B. J., Pereira-Smith, O. M., and Misteli, T. (2010). Regulation of alternative splicing by histone modifications, Science, 327, pp. 996–1000. 21. Bonetta, L. (2006). Genome sequencing in the fast lane, Nat. Methods, 3, pp. 141–147. 22. Romero, P. A., and Arnold, F. H. (2009). Exploring protein fitness landscapes by directed evolution, Nat. Rev. Mol. Cell Biol., 10, pp. 866– 876. 23. Lewis, J. C., and Arnold, F. H. (2009). Oxidations by laboratory-evolved cytochrome P450 BM3, Chimia, 63, pp. 309–312. 24. Kubo, T., Peters, M. W., Meinhold, P., and Arnold, F. H. (2006). Enantioselective epoxidation of terminal alkenes to (R)and (S)epoxides by engineered cytochromes P450 BM-3, Chemistry, 12, pp. 1216–1220. 25. Meinhold, P., Peters, M. W., Chen, M. M. Y., Takahashi, K., and Arnold, F. H. (2005). direct conversion of ethane to ethanol by engineered cytochrome P450 BM3, ChemBioChem, 6, pp. 1765–1768.